ReEmerge exited stealth with an oversubscribed $37M Series A to develop Cognitive Network Restoration Therapy, a deep brain stimulation approach for chronic cognitive impairment. The therapy targets the central lateral thalamus to reactivate underused neural circuits involved in attention, arousal, and executive function. ReEmerge will initially target traumatic brain injury, with a 40-patient multicenter trial planned.
.svg)
